These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 12052709)
1. Chemistry for peptide and protein PEGylation. Roberts MJ; Bentley MD; Harris JM Adv Drug Deliv Rev; 2002 Jun; 54(4):459-76. PubMed ID: 12052709 [TBL] [Abstract][Full Text] [Related]
2. PEGylation, successful approach to drug delivery. Veronese FM; Pasut G Drug Discov Today; 2005 Nov; 10(21):1451-8. PubMed ID: 16243265 [TBL] [Abstract][Full Text] [Related]
3. PEGylation: an approach for drug delivery. A review. Jain A; Jain SK Crit Rev Ther Drug Carrier Syst; 2008; 25(5):403-47. PubMed ID: 19062633 [TBL] [Abstract][Full Text] [Related]
4. Introduction and overview of peptide and protein pegylation. Veronese FM; Harris JM Adv Drug Deliv Rev; 2002 Jun; 54(4):453-6. PubMed ID: 12052707 [No Abstract] [Full Text] [Related]
6. PEGylation of cytokines and other therapeutic proteins and peptides: the importance of biological optimisation of coupling techniques. Francis GE; Fisher D; Delgado C; Malik F; Gardiner A; Neale D Int J Hematol; 1998 Jul; 68(1):1-18. PubMed ID: 9713164 [TBL] [Abstract][Full Text] [Related]
7. The impact of PEGylation on biological therapies. Veronese FM; Mero A BioDrugs; 2008; 22(5):315-29. PubMed ID: 18778113 [TBL] [Abstract][Full Text] [Related]
8. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge. Balan S; Choi JW; Godwin A; Teo I; Laborde CM; Heidelberger S; Zloh M; Shaunak S; Brocchini S Bioconjug Chem; 2007; 18(1):61-76. PubMed ID: 17226958 [TBL] [Abstract][Full Text] [Related]
9. Peptide and protein PEGylation: a review of problems and solutions. Veronese FM Biomaterials; 2001 Mar; 22(5):405-17. PubMed ID: 11214751 [TBL] [Abstract][Full Text] [Related]
10. PEG conjugates in clinical development or use as anticancer agents: an overview. Pasut G; Veronese FM Adv Drug Deliv Rev; 2009 Nov; 61(13):1177-88. PubMed ID: 19671438 [TBL] [Abstract][Full Text] [Related]
11. PEG - a versatile conjugating ligand for drugs and drug delivery systems. Kolate A; Baradia D; Patil S; Vhora I; Kore G; Misra A J Control Release; 2014 Oct; 192():67-81. PubMed ID: 24997275 [TBL] [Abstract][Full Text] [Related]
12. Modification of antimicrobial peptide with low molar mass poly(ethylene glycol). Zhang G; Han B; Lin X; Wu X; Yan H J Biochem; 2008 Dec; 144(6):781-8. PubMed ID: 18845567 [TBL] [Abstract][Full Text] [Related]
13. PEGylation and HAylation via catechol: α-Amine-specific reaction at N-terminus of peptides and proteins. Song IT; Lee M; Lee H; Han J; Jang JH; Lee MS; Koh GY; Lee H Acta Biomater; 2016 Oct; 43():50-60. PubMed ID: 27424082 [TBL] [Abstract][Full Text] [Related]
14. Preparation of biodegradable peptide nanospheres with hetero PEG brush surfaces. Matsumoto M; Matsusaki M; Akashi M Macromol Biosci; 2014 Jan; 14(1):142-50. PubMed ID: 24106226 [TBL] [Abstract][Full Text] [Related]
16. Recent advances on patents in poly(ethylene glycol)-based drug delivery. Bonora GM; Drioli S Recent Pat Drug Deliv Formul; 2008; 2(2):189-95. PubMed ID: 19075907 [TBL] [Abstract][Full Text] [Related]
17. Site-specific PEGylation of therapeutic proteins via optimization of both accessible reactive amino acid residues and PEG derivatives. Zhang C; Yang XL; Yuan YH; Pu J; Liao F BioDrugs; 2012 Aug; 26(4):209-15. PubMed ID: 22721556 [TBL] [Abstract][Full Text] [Related]